Feature | Atrial Fibrillation | November 07, 2017

New Data and Technology To Treat Atrial Fibrillation

Acutus dipole density EP mapping for ablation procedures.

The FDA recently cleared high-speed Acutus Medical's AcQMap High Resolution image and mapping system and the AcQMap 3-D Imaging and Mapping Catheter.  detects and displays both standard voltage-based and higher resolution dipole density (charge-source) maps. The system combines ultrasound anatomy construction with an ability to map the electrical-conduction of each heartbeat to identify complex arrhythmias across the entire atrial chamber. Following each ablation treatment, the heart can be re-mapped in seconds to continually visualize any changes from the prior mapping.



November 7, 2017 — Here is an aggregated list of articles detailing the latest clinical data and new device technology news for treating atrial fibrillation (AF or Afib) from the past six months. 

New Technologies to Improve Atrial Fibrillation Ablation

Boston Scientific to Acquire EP Technology Company Apama Medical

VIDEO: Current State of Atrial Fibrillation Ablation Technologies - Interview with Hugh Calkins, M.D.

Intracardiac Echo Should be More Widely Adopted to Minimize Radiation in Catheter Ablations

Mixed Results in PREVAIL Trial Comparing Five-Year Data for LAA Closure Compared to Warfarin

First Smartphone Compatible Insertable Cardiac Monitor Cleared by FDA

Wearable Cardiac Monitors Are Effective for Tracking Atrial Fibrillation Following Ablation

Implantable Cardiac Monitors Detect High Rate of Atrial Fibrillation in Previously Undiagnosed High-Risk Patients

Acutus Medical Receives FDA Clearance for AcQMap Cardiac Mapping Technology

Cryoballoon Ablation Reduces Costs and Resource Utilization

Multi-Electrode RF Balloon Efficient for Acute Pulmonary Vein Isolation

What is New in Electrophysiology Technologies

Smartphone Apps Help Patients and Providers Manage Atrial Fibrillation

CardioFocus Gains European CE Mark for HeartLight Excalibur Laser Ablation Balloon

Medtronic Announces First Enrollments in STOP AF First Clinical Trial

Expert Consensus Released on Catheter, Surgical Ablation of Atrial Fibrillation

Analysis Shows Increased Risk of Early Stroke with New-Onset Atrial Fibrillation Post-TAVR

CASTLE-AF Study Results Indicate Catheter Ablation of Atrial Fibrillation as First-Line Treatment for Heart Failure Patients

Heart Rhythm Society 2017 Late-Breaking Electrophysiology Trials

EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion

Real-World Analysis Compares Safety, Effectiveness of Apixaban Versus Warfarin

UNC School of Medicine Receives $1.7 Million for Atrial Fibrillation Program Streamlining Patient Care

VIDEO: Demonstration of the AcQMap High-resolution EP Mapping System

Stroke History Higher in Asymptomatic Versus Symptomatic Atrial Fibrillation Patients

Positive European Registry Results For Watchman Left Atrial Appendage Closure Device

Closure of Left Atrial Appendage During Heart Surgery Protects the Brain

Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System

Confirm RX First Implantable Cardiac Monitor to Gain European Approval Using Mobile Phone App Monitoring

Medtronic Reactive ATP Therapy Slows Progression of Atrial Fibrillation in Real-World Population

Newer Anticoagulant Reduces Major Bleeds in AF Ablation

Most Atrial Fibrillation Patients Do Not Get Preventive Drug Before Stroke


Related Content

Stereotaxis Receives Regulatory Approval of e-Contact Module in Canada
Technology | Ablation Systems | December 08, 2017
December 7, 2017 — Stereotaxis Inc.
CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems | October 10, 2017
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Ball
The Apama Radiofrequency (RF) Balloon Catheter System.
News | Ablation Systems | October 02, 2017
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems | August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems | July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biosense Webster multi-electrode RF ablation balloon

Biosense Webster's multi-electrode RF ablation balloon with irrigation. The system allows operators to change the energy levels of each electrode to avoid damaging sensitive underlying critical structures like the esophagus or phrenic nerve.

Feature | Ablation Systems | May 17, 2017 | Dave Fornell
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigatio
Abbott Announces CE Mark for New Cardiac Ablation Catheter
News | Ablation Systems | May 10, 2017
Abbott announced CE Mark of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, developed to make it easier...
Medtronic, expanded indication, Freezor Xtra Cryoablation Catheter, AVNRT, atrioventricular nodal re-entrant tachycardia
Technology | Ablation Systems | February 16, 2017
Medtronic plc announced the U.S. Food and Drug Administration (FDA) has approved its Freezor Xtra Cryoablation Catheter...
CardioFocus, HeartLight Excalibur Balloon, 22nd Annual AF Symposium, atrial fibrillation, initial clinical evaluation
News | Ablation Systems | January 25, 2017
CardioFocus Inc. recently announced the initial clinical evaluation of the HeartLight Excalibur Balloon, a next-...
catheter ablations, atrial fibrillation, stroke risk, Intermountain Medical Center Heart Institute study, AHA Scientific Sessions, American Heart Association
News | Ablation Systems | November 14, 2016
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation lower their long-term risk of...
Overlay Init